Danaher Corporation Share Price NYSE
Stocks
DHR PRB
US2358514097
Advanced Medical Equipment & Technology
| Market Cap | 141B 121B 115B 104B 195B 13,442B 196B 1,363B 524B 6,831B 528B 517B 21,604B | P/E 2026 * |
33.8x | P/E 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 161B 139B 132B 119B 224B 15,410B 225B 1,562B 601B 7,832B 606B 592B 24,768B | EV / Sales 2026 * |
6.12x | EV / Sales 2027 * | 5.51x |
| Free-Float |
70.45% | Yield 2026 * |
0.7% | Yield 2027 * | 0.78% |
Last Transcript : Danaher Corporation
| 1 day | -0.78% |
| Manager | Title | Age | Since |
|---|---|---|---|
Rainer Blair
CEO | Chief Executive Officer | 62 | 31/08/2020 |
Matthew Gugino
DFI | Director of Finance/CFO | - | 27/02/2026 |
Steven Dee
CTO | Chief Tech/Sci/R&D Officer | - | 24/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Spoon
BRD | Director/Board Member | 74 | 30/06/1999 |
Steven Rales
CHM | Chairman | 74 | 31/12/1983 |
Mitchell Rales
BRD | Director/Board Member | 69 | 31/12/1983 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.78% | +1.02% | - | - | 141B | |
| +1.10% | -0.65% | +24.10% | +18.43% | 225B | |
| -0.19% | -3.62% | +2.55% | -20.00% | 141B | |
| +2.41% | +0.67% | -19.02% | +22.09% | 130B | |
| -0.28% | -10.08% | -58.81% | -21.22% | 62.29B | |
| -2.77% | -6.15% | +8.15% | +12.69% | 48.63B | |
| -0.49% | -1.97% | -20.35% | -15.53% | 49.39B | |
| +2.66% | -2.61% | +15.94% | +29.91% | 41.42B | |
| +1.67% | -0.25% | +35.01% | +55.09% | 40.12B | |
| -0.60% | -4.41% | -20.52% | +44.06% | 31.23B | |
| Average | +0.27% | -3.42% | -3.66% | +13.95% | 85.52B | |
| Weighted average by Cap. | +0.45% | -2.50% | +0.60% | +9.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.34B 22.71B 21.49B 19.48B 36.53B 2,516B 36.74B 255B 98.06B 1,279B 98.91B 96.72B 4,044B | 28.45B 24.54B 23.22B 21.05B 39.46B 2,719B 39.7B 276B 106B 1,382B 107B 105B 4,369B |
| Net income | 4.2B 3.63B 3.43B 3.11B 5.83B 402B 5.87B 40.72B 15.65B 204B 15.79B 15.44B 646B | 5.15B 4.44B 4.2B 3.81B 7.14B 492B 7.18B 49.84B 19.16B 250B 19.33B 18.9B 790B |
| Net Debt | 20.6B 17.76B 16.81B 15.24B 28.57B 1,968B 28.74B 199B 76.7B 1,000B 77.36B 75.65B 3,163B | 16.19B 13.96B 13.21B 11.98B 22.45B 1,547B 22.59B 157B 60.28B 786B 60.8B 59.46B 2,486B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
